Febuxostat Use Among Gout Patients Linked to Increased Cardiovascular Risk in new study
Us of Febuxostat linked to increased CV risk among Asians suggests a new study published in the Clinical and Translational Science. The cardiovascular (CV) safety of febuxostat compared to allopurinol for the treatment of hyperuricemia among Asian patients is uncertain. In this study, we conducted a systematic review and meta-analysis to compare the CV safety […]